Infinity and Intellikine to develop oral PI3K inhibitors for inflammatory diseases

被引:0
作者
机构
来源
Nature Reviews Drug Discovery | 2010年 / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:670 / 670
相关论文
共 50 条
[31]   THE ROLE OF CDK AND PI3K/MTOR INHIBITORS [J].
Andre, Fabrice .
BREAST, 2015, 24 :S25-S25
[32]   Challenges in the clinical development of PI3K inhibitors [J].
Massacesi, Cristian ;
di Tomaso, Emmanuelle ;
Fretault, Nathalie ;
Hirawat, Samit .
INOSITOL PHOSPHOLIPID SIGNALING IN PHYSIOLOGY AND DISEASE, 2013, 1280 :19-23
[33]   Development and safety of PI3K inhibitors in cancer [J].
Miaomiao Yu ;
Jiajia Chen ;
Zhifei Xu ;
Bo Yang ;
Qiaojun He ;
Peihua Luo ;
Hao Yan ;
Xiaochun Yang .
Archives of Toxicology, 2023, 97 :635-650
[34]   Discovery of Potent and Selective PI3Kγ Inhibitors [J].
Drew, Samuel L. ;
Thomas-Tran, Rhiannon ;
Beatty, Joel W. ;
Fournier, Jeremy ;
Lawson, Kenneth, V ;
Miles, Dillon H. ;
Mata, Guillaume ;
Sharif, Ehesan U. ;
Yan, Xuelei ;
Mailyan, Artur K. ;
Ginn, Elaine ;
Chen, Jie ;
Wong, Kent ;
Soni, Divyank ;
Dhanota, Puja ;
Chen, Pei-Yu ;
Shaqfeh, Stefan G. ;
Meleza, Cesar ;
Pham, Amber T. ;
Chen, Ada ;
Zhao, Xiaoning ;
Banuelos, Jesus ;
Jin, Lixia ;
Schindler, Ulrike ;
Walters, Matthew J. ;
Young, Stephen W. ;
Walker, Nigel P. ;
Leleti, Manmohan Reddy ;
Powers, Jay P. ;
Jeffrey, Jenna L. .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) :11235-11257
[35]   Discovery of imidazopyridine and imidazopyridazine inhibitors of PI3K [J].
Han, Wooseok ;
Pecchi, Sabina ;
Burger, Matthew ;
Lan, Jiong ;
Smith, Aaron ;
Knapp, Mark ;
Huh, Kay ;
De Menezes, Daniel Lopes ;
Jansen, Johanna ;
Merritt, Hanne ;
Kaufman, Susan ;
Voliva, Charles .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[36]   Modulation of mitochondrial apoptosis by PI3K inhibitors [J].
Fulda, Simone .
MITOCHONDRION, 2013, 13 (03) :195-198
[37]   Development of PI3Kα inhibitors for tumor therapy [J].
Jia, Wenqing ;
Luo, Shuyu ;
Guo, Han ;
Kong, Dexin .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (17) :8587-8604
[38]   PI3K pathway inhibitors approach junction [J].
Holmes, David .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) :563-565
[39]   Development and safety of PI3K inhibitors in cancer [J].
Yu, Miaomiao ;
Chen, Jiajia ;
Xu, Zhifei ;
Yang, Bo ;
He, Qiaojun ;
Luo, Peihua ;
Yan, Hao ;
Yang, Xiaochun .
ARCHIVES OF TOXICOLOGY, 2023, 97 (03) :635-650
[40]   PI3K inhibitors in thrombosis and cardiovascular disease [J].
Durrant, Tom N. ;
Hers, Ingeborg .
CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 9 (01)